Although the number of recurrent GBMs in was much smaller, BIRC3 was expressed at significantly higher level (p = 0.0072, group- median difference =1.5 log2 units) in recurrent GBM patients (n = 13) than that of newly diagnosed GBM patients (n = 156), see Fig. 1e. Here, BIRC3 is linked to glioblastoma.